Bone and Joint Infection
Conditions
Keywords
osteo articular infection, adverse event, antibiotic treatment, pharmaceutical interview
Brief summary
The primary objective is to evaluate the impact of Pharmaceutical Interviews in the patient self-management of non-severe side effects caused by antibiotics prescribed for the treatment of osteoarticular infections when the patient returns home.
Interventions
Pharmaceutical interview with pharmacist: to be informed treatment taken and related SAE informations at the end of hospitalization
Sponsors
Assistance Publique - Hôpitaux de Paris
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient \> or =18 years; * Informed consent signed; * French-speaking and reading; * Affiliated to a social insurance; * Benefiting from medical and surgical care for an osteoarticular infection; * Treated with an oral antibiotic therapy on discharge from hospital. * Indication of the antibiotic therapy osteoarticular infection; * Return home immediately after discharge.
Exclusion criteria
* Refusal to participate * Protected adult patient, under guardianship or curatorship. * Minor patient * Patient benefiting from an AME. * Pregnant or breastfeeding woman. * Non-French speaking patient. * Patient unable to understand the course of the study. * Patient with a documented history of cognitive or psychiatric disorders. * Patient treated with oral antibiotic therapy for an indication other than osteoarticular infection. * Patient treated with parenteral antibiotic therapy. * Discharge: Institution (EHPAD), rehabilitation or other health establishment. * Patient systematically using one of the symptomatic treatments proposed in the discharge prescription before hospitalization.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Adverse effects self-management measurement | at day 7 | Phone call to evaluate the self-management of adverse effects. Self-management evaluation (optimal choice/non-optimal choice) performs thanks to the use of a standardized decision-tree. Proportion of patients with an optimal or non-optimal self-management. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient knowledge assessment | at day 7 | Questionnaire, 12 points: * proportion of patients reaching a score upper than 10 * proportion of patients reaching a score between 6 and 9 * proportion of patients reaching a score lower than 6 |
Countries
France
Outcome results
None listed